Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/25/2003US20030180945 Gene expression inhibition of any interest gene eukaryotic cells and organisms, with a chimeric antisense RNA molecule; genetic engineering, forming a transgenic eukaryotic organism, such as plants, animals or fungi, yeast or molds
09/25/2003US20030180937 Gene expression of reporter protein, exporting through the Twin Arginine Translocation pathway
09/25/2003US20030180936 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003US20030180935 ICE/CED-3 like protease designated FMH-1
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180933 Protease variants and compositions
09/25/2003US20030180932 Gene has a mutation or deletion of part of the genes, encoding a serine protease cleaning composition; biosynthesis
09/25/2003US20030180931 Cellubrevin homologs
09/25/2003US20030180929 Structure-based designed herbicide resistant products
09/25/2003US20030180928 A nucleic acids encoding the protein, host cells expressing the protein, comprising a catalytic domain of a glycosyltransferase, using in enzymatic synthesis of oligosaccharides
09/25/2003US20030180923 An amino acid sequence free of its associated signal peptide; fusion proteins, host cell of an E. coli or a yeast cell, immunomodulator, immunostimulants, cell proliferation, tumor detection, receptor binding assay
09/25/2003US20030180902 Method and apparatus for selectively targeting specific cells within a mixed cell population
09/25/2003US20030180898 Adding to a fermentation medium containing a microorganisms (algae, fungi, protists) carbon and nitrogen sources to increase the biomass density of the medium to atleast about 100 g/l, to produce lipids (polyenoic fatty acid)
09/25/2003US20030180895 Xylanse variants having altered sensitivity to xylanse inhibitors
09/25/2003US20030180894 Oligonucleotides and method for characterizing and detecting Genogroup II type small round structured virus
09/25/2003US20030180892 Interleukin-20
09/25/2003US20030180891 Connective tissue growth factor-4
09/25/2003US20030180889 Gene encoding HM1.24 antigen protein and promoter thereof
09/25/2003US20030180887 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/25/2003US20030180884 Culturing a basidiomycete under low temperature and conditions such that it produces an antifreeze protein; high antifreeze activity such as a thermal hysteresis activity or an ice-recrystallizatin inhibition property
09/25/2003US20030180882 Providing a yeast cell with reduced expression of either or both of the proteases encoded by yeast aspartyl protease-3 and MKC7 gene, transforming the yeast cell with a vector, expressing the polypeptide
09/25/2003US20030180881 PRO polypeptides; fusion proteins; immunoglobulins
09/25/2003US20030180880 Chromosome 1 gene and gene products related to alzheimer's disease
09/25/2003US20030180879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180876 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180875 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180874 PRO polypeptides; fusion proteins; immunoglobulins; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells; for stimulating release of proteoglycans from cartilage
09/25/2003US20030180873 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180871 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
09/25/2003US20030180870 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
09/25/2003US20030180868 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180866 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage
09/25/2003US20030180865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180835 Contacting the glycopeptide with a reaction mixture that contains a fucose donor group and first fucosyltransferase to transfer fucose from fucose donor group to the acceptor group, such glycopeptide has a uniform fucosylation pattern
09/25/2003US20030180834 Novel compounds
09/25/2003US20030180832 Expressing an uncoupled ATPase activity in a specific cell to induce conversion of ATP to ADP without primary effects on the cellular metabolites or functions, and incubating the cell with a suitable substrate to prodcue the biomass
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180817 Determining levels of a colon specific gene in the cells, or bodily fluids in a patient, comparing determined levels of CSG with levels of CSG in cells from normal human control, wherein a change in level of CSG indicates presence of cancer
09/25/2003US20030180816 Method to provide bacterial ghosts provided with antigens
09/25/2003US20030180813 Method of screening remedy for diabetes
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180808 Drug signatures
09/25/2003US20030180807 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
09/25/2003US20030180802 Nematode fatty acid desaturase-like sequences
09/25/2003US20030180801 Comprises fusion proteins with green fluorescent protein to construct gene expression library; transcription factors; for treating tumor necrosis factor-related diseases
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180791 Anti-proliferation domain of human Bcl-2 and DNA encoding the same
09/25/2003US20030180787 Isopentenyl diphosphate biosynthetic enzymes
09/25/2003US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180782 Comprises pipetting robot or voltage-driven fluidic transport for hybridization
09/25/2003US20030180781 High speed hybridization of oligonucleotides with polymerases/exonucleases
09/25/2003US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
09/25/2003US20030180777 Rapid identification of transcriptional regulatory domains
09/25/2003US20030180765 Dividing a test fecal sample of a patient to form multiple aliquots containing BAT26 alleles, amplifying the alleles to form amplified templates, amplifying templates using first and third primer to form subtempletes, analyzing altered size
09/25/2003US20030180764 Genes affected by cholesterol treatment and during adipogenesis
09/25/2003US20030180761 Map-based genome mining method for identifying regulatory loci controlling the level of gene transcripts and products
09/25/2003US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen
09/25/2003US20030180758 Co-amplifying a set of at least three microsatellite loci of genomic DNA, containing one mononucleotide repeat locus and atleast two tetranucleotide repeat loci, from the sample of genomic DNA in a multiplex amplification reaction
09/25/2003US20030180756 Nucleic acids encoding RNAs targeting specific genes (in eukaryotic cells) and thereby inhibiting expression of these genes and expression of abnormal mutated protein
09/25/2003US20030180754 Nucleic acid isolation
09/25/2003US20030180753 Full length human hcn1ih channel subunit and variants
09/25/2003US20030180752 Type 2 cytokine receptor and nucleic acids encoding same
09/25/2003US20030180751 A polypeptides involved in the lignin, tannin and fructan biosynthetic pathways, and a preferred polynucleotides encoding such polypeptide
09/25/2003US20030180750 Treatment of cancer and neurological diseases
09/25/2003US20030180744 High affinity oligonucleotide ligands to growth factors
09/25/2003US20030180742 A polypetide; catalyzes the hydrolysis of epoxides and arene oxides to their corresponding diols
09/25/2003US20030180741 High fidelity DNA polymerase compositions and uses therefor
09/25/2003US20030180740 Identifying a genetic element whose expression differs, when gene expression in first and/or second cell is compared under at least two different environmental conditins relevant ot the cellular proecess
09/25/2003US20030180739 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence
09/25/2003US20030180737 Method of reverse transcription
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180729 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
09/25/2003US20030180726 Compositions and methods relating to ovarian specific genes and proteins
09/25/2003US20030180718 Target specific screening and its use for identifying target binders
09/25/2003US20030180716 Microbe indentifying method, microbe identifying apparatus, method for creating database for microbe identification, microbe identifying program, and recording medium on which the same is recorded
09/25/2003US20030180715 Methods and means for assessing HIV envelope inhibitor therapy
09/25/2003US20030180714 Shotgun scanning
09/25/2003US20030180713 Contacting a first cell with the compound, determining a first value of a property of the first cell, contacting second cell containing zinc finger protein which modulates expression of the molecular target, determining second value of the cell
09/25/2003US20030180712 Host cells transfected with a recombinant expression vector containing nucleic acid control sequences operatively linked to an L-type Ca2+ channel beta 3 gene; host cell free of functional beta 3 subunit-containing L-type Ca2+ channels
09/25/2003US20030180707 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site
09/25/2003US20030180348 Transcellular drug delivery system
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180324 Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use
09/25/2003US20030180322 Genome segments; detection of phenotype
09/25/2003US20030180321 Mycobacterial sulfation pathway proteins and methods of use thereof
09/25/2003US20030180320 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries
09/25/2003US20030180317 Diagnosis ear infections in children
09/25/2003US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
09/25/2003US20030180313 Genetic engineering; detection of humans immunodeficiency virus infections
09/25/2003US20030180309 Autoimmune disease; antiinflammatory agents; antiallergens; antihistamines; d
09/25/2003US20030180307 Polypeptides; detecting infections using antibodies
09/25/2003US20030180306 Controlling cell differentiation; muscular disorders
09/25/2003US20030180303 Lipopolysaccharide binding protein derivatives
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180296 Antibodies that immunospecifically bind to trail receptors
1 ... 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 ... 4023